GLOBAL RHINOLOGY NETWORK CIC

Company limited by guarantee

Company Registration Number:
12540578 (England and Wales)

Unaudited statutory accounts for the year ended 30 September 2024

Period of accounts

Start date: 1 October 2023

End date: 30 September 2024

GLOBAL RHINOLOGY NETWORK CIC

Contents of the Financial Statements

for the Period Ended 30 September 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

GLOBAL RHINOLOGY NETWORK CIC

Profit And Loss Account

for the Period Ended 30 September 2024

2024 2023


£

£
Turnover: 55,773 102,208
Gross profit(or loss): 55,773 102,208
Administrative expenses: ( 57,069 ) ( 100,602 )
Other operating income: 85
Operating profit(or loss): (1,211) 1,606
Profit(or loss) before tax: (1,211) 1,606
Profit(or loss) for the financial year: (1,211) 1,606

GLOBAL RHINOLOGY NETWORK CIC

Balance sheet

As at 30 September 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 6,170 3,674
Total fixed assets: 6,170 3,674
Current assets
Debtors: 4 1,515
Cash at bank and in hand: 744 2,933
Total current assets: 744 4,448
Net current assets (liabilities): 744 4,448
Total assets less current liabilities: 6,914 8,122
Creditors: amounts falling due after more than one year: 5 ( 961 ) ( 958 )
Total net assets (liabilities): 5,953 7,164
Members' funds
Profit and loss account: 5,953 7,164
Total members' funds: 5,953 7,164

The notes form part of these financial statements

GLOBAL RHINOLOGY NETWORK CIC

Balance sheet statements

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 June 2025
and signed on behalf of the board by:

Name: A Rokade
Status: Director

The notes form part of these financial statements

GLOBAL RHINOLOGY NETWORK CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GLOBAL RHINOLOGY NETWORK CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 2 2

GLOBAL RHINOLOGY NETWORK CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 October 2023 2,778 1,132 3,910
Additions 2,779 1,049 3,828
Disposals
Revaluations
Transfers
At 30 September 2024 5,557 2,181 7,738
Depreciation
At 1 October 2023 70 166 236
Charge for year 788 544 1,332
On disposals
Other adjustments
At 30 September 2024 858 710 1,568
Net book value
At 30 September 2024 4,699 1,471 6,170
At 30 September 2023 2,708 966 3,674

GLOBAL RHINOLOGY NETWORK CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

4. Debtors

2024 2023
£ £
Other debtors 1,515
Total   1,515

GLOBAL RHINOLOGY NETWORK CIC

Notes to the Financial Statements

for the Period Ended 30 September 2024

5. Creditors: amounts falling due after more than one year note

2024 2023
£ £
Other creditors 961 958
Total 961 958

COMMUNITY INTEREST ANNUAL REPORT

GLOBAL RHINOLOGY NETWORK CIC

Company Number: 12540578 (England and Wales)

Year Ending: 30 September 2024

Company activities and impact

Global Rhinology network is a registered non-profit organisation with the mission to host surgical training in the field of Rhinology and Skull base Surgery. The concept of the mission was developed through the annual international live surgical webcast the LIONESS by Mr Rokade with the strong support of participating surgeons in association with the LION foundation. GRN has hosted various global surgical events, which include GRE SS, 2020 and LION ESS2021. Four more events were hosted within the last year. These events are as follows: 1.GRN journey to excellence, Friday, 21 April 2023. 2.GRN literary lounge, a book review session, Friday 31st of March 2023. 3.GRN Topical Research symposium, December 6, 2022 4.Festschrift to Prof Claus Bachert Wednesday 24 August 2022.

Consultation with stakeholders

The stakeholders of the CIC are the medical professional around the world that are interested in the CIC's activities. The scientific advisory committee has been consulted from time to time about organising various educational events. The advice received has been taken on board and implemenetd as when practicable and in line with the CIC's mission.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
16 June 2025

And signed on behalf of the board by:
Name: A Rokade
Status: Director